Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population

Cancer Genetics and Cytogenetics

Volumn 169, Issue 1, 2006, Pages 39-44

  Park, Kyong Hwa ^a   Lo Han, Sle Gi ^a   Whang, Young Mi ^a   Lee, Hyo Jung ^b   Yoo, Young Do ^a   Lee, Jae Won ^b   Shin, Sang Won ^a   Kim, Yeul Hong ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; LUCIFERASE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KOREA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; GENOTYPE; HUMANS; KOREA; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746265306     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.03.012     Document Type: Article

References (27)

1. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor β in human disease. N Engl J Med 342 (2000) 1350-1358 [Erratum in: N Engl J Med 2000;343;228]
2. Laiho M., DeCaprio J.A., Ludlow J.W., Livingston D.M., and Massague J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62 (1990) 175-185
3. Moses H.L., Yang E.Y., and Pietenpol J.A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63 (1990) 245-247
4. Derynck R., Goeddel D.V., Ullrich A., Gutterman J.U., Williams R.D., Bringman T.S., and Berger W.H. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47 (1987) 707-712
5. Dickson R.B., Kasid A., Huff K.K., Bates S.E., Knabbe C., Bronzert D., Gelmann E.P., and Lippman M.E. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci U S A 84 (1987) 837-841
6. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
7. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., and Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18 (1999) 1280-1291
8. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., and Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121 (1995) 1845-1854
9. Maehara Y., Kakeji Y., Kabashima A., Emi Y., Watanabe A., Akazawa K., Baba H., Kohnoe S., and Sugimachi K. Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17 (1999) 607-614
10. Picon A., Gold L.I., Wang J., Cohen A., and Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1. Cancer Epidemiol Biomarkers Prev 7 (1998) 497-504
11. Kong F.M., Washington M.K., Jirtle R.L., and Anscher M.S. Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer 16 (1996) 47-59
12. Kong F., Jirtle R.L., Huang D.H., Clough R.W., and Anscher M.S. Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 86 (1999) 1712-1719
13. Hasegawa Y., Takanashi S., Kanehira Y., Tsushima T., Imai T., and Okumura K. Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91 (2001) 964-971
14. Watanabe Y., Kinoshita A., Yamada T., Ohta T., Kishino T., Matsumoto N., Ishikawa M., Niikawa N., and Yoshiura K. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-β1 (TGF-β1) and its signaling pathway. J Hum Genet 47 (2002) 478-483
15. Shu X.O., Gao Y.T., Cai Q., Pierce L., Cai H., Ruan Z.X., Yang G., Jin F., and Zheng W. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 64 (2004) 836-839
16. Grainger D.J., Percival J., Chiano M., and Spector T.D. The role of serum TGF-β isoforms as potential markers of osteoporosis. Osteoporos Int 9 (1999) 398-404
17. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., and Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease. Hum Genet 106 (2000) 565-569
18. Silverman E.S., Palmer L.J., Subramaniam V., Hallock A., Mathew S., Vallone J., Faffe D.S., Shikanai T., Raby B.A., Weiss S.T., and Shore S.A. Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 169 (2004) 214-219
19. Derynck R., Rhee L., Chen E.Y., and Van Tilburg A. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res 15 (1987) 3188-3189
20. Crilly A., Hamilton J., Clark C.J., Jardine A., and Madhok R. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis 61 (2002) 678-681
21. Kim Y.J., Lee H.S., Im J.P., Min B.H., Kim H.D., Jeong J.B., Yoon J.H., Kim C.Y., Kim M.S., Kim J.Y., Jung J.H., Kim L.H., Park B.L., and Shin H.D. Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35 (2003) 196-202
22. Schneider J., Classen V., Bernges U., and Philipp M. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med 16 (2005) 709-716
23. Larsen J.E., Colosimo M.L., Yang I.A., Bowman R., Zimmerman P.V., and Fong K.M. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 27 (2005) 525-532
24. Wu L., Chau J., Young R.P., Pokorny V., Mills G.D., Hopkins R., McLean L., and Black P.N. Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 59 (2004) 126-129
25. Su Z.G., Wen F.Q., Feng Y.L., Xiao M., and Wu X.L. Transforming growth factor-β1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin 26 (2005) 714-720
26. Yamada Y. Association of a Leu(10)→Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mech Ageing Dev 116 (2000) 113-123
27. Ziv E., Kahn A., Cauley J., Morin P., Saiz R., and Browner W. No association between the TGF-β1 Leu10Pro polymorphism and osteoporosis among white women in the United States. Am J Med 114 (2003) 227-231